Lexicon Pharmaceuticals
LXRX
#7142
Rank
โ‚ฌ0.43 B
Marketcap
1,20ย โ‚ฌ
Share price
-1.41%
Change (1 day)
78.94%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Net assets

Net assets on the balance sheet as of September 2025 : โ‚ฌ0.10 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company has โ‚ฌ0.10 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Lexicon Pharmaceuticals - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$โ‚ฌ0.14 B66.52%
2023-12-31$โ‚ฌ84.22 M-22.86%
2022-12-31$โ‚ฌ0.10 B8.86%
2021-12-31$โ‚ฌ0.10 B-21.1%
2020-12-31$โ‚ฌ0.12 B21.62%
2019-12-31$โ‚ฌ0.10 B-552.89%
2018-12-31$-โ‚ฌ23.09 Million-140.57%
2017-12-31$โ‚ฌ56.89 M-61.98%
2016-12-31$โ‚ฌ0.14 B-42.76%
2015-12-31$โ‚ฌ0.26 B11.95%
2014-12-31$โ‚ฌ0.23 B89.53%
2013-12-31$โ‚ฌ0.12 B-38.88%
2012-12-31$โ‚ฌ0.20 B-12.01%
2011-12-31$โ‚ฌ0.22 B23.38%
2010-12-31$โ‚ฌ0.18 B62.74%
2009-12-31$โ‚ฌ0.11 B-18.53%
2008-12-31$โ‚ฌ0.14 B-28.63%
2007-12-31$โ‚ฌ0.19 B202.89%
2006-12-31$โ‚ฌ64.79 M-10.54%
2005-12-31$โ‚ฌ72.43 M-19.2%
2004-12-31$โ‚ฌ89.63 M-32.1%
2003-12-31$โ‚ฌ0.13 B-18.77%
2002-12-31$โ‚ฌ0.16 B-34.27%
2001-12-31$โ‚ฌ0.24 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Eterna Therapeutics
ERNA
โ‚ฌ3.06 M-97.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ26.58 B 25,664.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
โ‚ฌ13.87 M-86.55%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ5.20 B 4,940.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚ฌ43.93 B 42,471.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚ฌ0.39 Billion-475.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚ฌ2.04 B 1,881.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ0.81 B 690.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚ฌ0.15 Billion-236.47%๐Ÿ‡บ๐Ÿ‡ธ USA